Jessica Gosnell, MD

Endocrine surgeon

Dr. Jessica Gosnell is a surgeon who specializes in treating endocrine glands, particularly the thyroid and parathyroid. In her research, she studies new treatments for thyroid cancer and is involved in several clinical trials.

She earned a medical degree at the University of Washington in Seattle and completed a residency in general surgery at UCSF, where she received the Hunicutt Resident Award for Excellence in Teaching for two years. She also received a Gastrointestinal Research Training Grant from the National Institutes of Health as a research fellow at San Francisco General Hospital and completed a fellowship in endocrine surgery at the University of Sydney in Australia. Gosnell is an associate professor of surgery at UCSF.

Clinics

Endocrine Surgery and Oncology Clinic
1600 Divisadero St., Fourth Floor
San Francisco, CA 94115
Phone: (415) 353-7687
Fax: (415) 353-7781

Hours: Monday to Friday,
9 a.m. – 5 p.m.

Conditions & Treatments

Board Certification

Surgery, American Board of Surgery

Academic Title

Associate Professor

More about Jessica Gosnell

Additional Languages

French

Education

University of Washington School of Medicine 1995

Residencies

UCSF Medical Center, General Surgery 2002

Fellowships

Royal North Shore Hospital, Sydney, Endocrine Surgery 2003

Selected Research and Publications

  1. Seib CD, Rochefort H, Chomsky-Higgins K, Gosnell JE, Suh I, Shen WT, Duh QY, Finlayson E. Association of Patient Frailty With Increased Morbidity After Common Ambulatory General Surgery Operations. JAMA Surg. 2018 Feb 01; 153(2):160-168.
  2. Chomsky-Higgins KH, Rochefort HM, Seib CD, Gosnell JE, Shen WT, Duh QY, Suh I. Recombinant Parathyroid Hormone Versus Usual Care: Do the Outcomes Justify the Cost? World J Surg. 2018 02; 42(2):431-436.
  3. Asban A, Kluijfhout WP, Drake FT, Beninato T, Wang E, Chomsky-Higgins K, Shen WT, Gosnell JE, Suh I, Duh QY. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center. J Surg Oncol. 2018 Jan 08.
  4. Gosnell JE, Duh QY. Medullary Thyroid Carcinoma-We Should Do Better. JAMA Surg. 2018 Jan 01; 153(1):59.
  5. Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, Duh QY, Suh I. Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas. Surgery. 2018 Jan; 163(1):197-204.
  6. Beninato T, Kluijfhout WP, Drake FT, Khanafshar E, Gosnell JE, Shen WT, Duh QY, Suh I. Squamous differentiation in papillary thyroid carcinoma: a rare feature of aggressive disease. J Surg Res. 2018 Mar; 223:39-45.
  7. Duh QY, Gosnell JE. Improvement of TNM Staging for Medullary Thyroid Cancer. JAMA Surg. 2017 Sep 01; 152(9):876-877.
  8. Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, de Keizer B, Hope TA, Glastonbury CM, Pampaloni MH, Suh I. 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study. Radiology. 2017 08; 284(2):460-467.
  9. Kluijfhout WP, Drake FT, Pasternak JD, Beninato T, Mitmaker EJ, Gosnell JE, Shen WT, Suh I, Freise CE, Duh QY. De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature. J Surg Oncol. 2017 Feb; 115(2):105-108.
  10. Kluijfhout WP, Pasternak JD, Beninato T, Drake FT, Gosnell JE, Shen WT, Duh QY, Allen IE, Vriens MR, de Keizer B, Hope TA, Suh I. Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis. Eur J Radiol. 2017 Mar; 88:117-128.
  11. Kluijfhout WP, Beninato T, Drake FT, Vriens MR, Gosnell J, Shen WT, Suh I, Liu C, Duh QY. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. World J Surg. 2016 12; 40(12):2964-2969.
  12. Beninato T, Kluijfhout WP, Drake FT, Lim J, Kwon JS, Xiong M, Shen WT, Gosnell JE, Liu C, Suh I, Duh QY. Resection of Pheochromocytoma Improves Diabetes Mellitus in the Majority of Patients. Ann Surg Oncol. 2017 May; 24(5):1208-1213.
  13. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Shen WT, Gosnell JE, Suh I, C L, Duh QY. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery. 2017 01; 161(1):127-133.
  14. Venkatesh S, Pasternak JD, Beninato T, Drake FT, Kluijfhout WP, Liu C, Gosnell JE, Shen WT, Clark OH, Duh QY, Suh I. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer. Surgery. 2017 01; 161(1):116-126.
  15. Applewhite MK, White MG, Xiong M, Pasternak JD, Abdulrasool L, Ogawa L, Suh I, Gosnell JE, Kaplan EL, Duh QY, Angelos P, Shen WT, Grogan RH. Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery. Ann Surg Oncol. 2016 Dec; 23(13):4310-4315.
  16. Livhits MJ, Pasternak JD, Xiong M, Li N, Gosnell JE, Yeh MW, Chiu HK. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER. Endocr Pract. 2016 Nov; 22(11):1259-1266.
  17. Cox C, Chen Y, Cress R, Semrad AM, Semrad T, Gosnell JE, Campbell MJ. Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry. Gland Surg. 2016 Aug; 5(4):398-404.
  18. Kluijfhout WP, Pasternak JD, Lim J, Kwon JS, Vriens MR, Clark OH, Shen WT, Gosnell JE, Suh I, Duh QY. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4?cm Well-Differentiated Thyroid Cancer. Thyroid. 2016 06; 26(6):820-4.
  19. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, Duh QY, Allen IE, Vriens MR, de Keizer B, Pampaloni MH, Suh I. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg. 2016 Nov; 401(7):925-935.
  20. Kluijfhout WP, Pasternak JD, Kwon JS, Lim J, Shen WT, Gosnell JE, Khanafshar E, Duh QY, Suh I. Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1-T2 Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2016 May; 23(5):1446-51.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.